Lipid lowering in a multidisciplinary clinic compared with primary physician management

American Journal of Cardiology

Volumn 81, Issue 7, 1998, Pages 929-933

  Harris, David E ^a   Record, N Burgess ^b   Gipson, Gary W ^b   Pearson, Thomas A ^b  

^a UNIVERSITY OF SOUTHERN MAINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GLYCERYL TRINITRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATINE DERIVATIVE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

EID: 0032054762     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00027-7     Document Type: Article

References (19)

1. 1. Deedwania PC. Clinical perspectives on primary and secondary prevention of coronary atherosclerosis. Med Clin N Am 1995;79:973-998.
2. 2. Gotto AM, LaRosa JC, Hunninghake D, Grundy SM, Wilson PW, Clarkson TB Hay JW, Goodman DS. The cholesterol facts - a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation 1990;81:1721-1733.
3. 3. Waters D, Pedersen TR. Review of cholesterol-lowering therapy: coronary angiographic and events trials. Am J Med 1996;101:34s-38s.
4. 4. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel II). JAMA 1993;269:3015-3023.
5. 5. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MS, Krauss RM, Farquhar JW. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. Circulation 1994;89:975-990.
6. 6. Shalowitz M, Heaton AH. Cost effectiveness of risk reduction: the managed care perspective. Am J Med 1996;101:71s-75s.
7. 7. Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med 1997;336:332-336.
8. 8. Cohen MV, Byrne M, Levine B, Gutowski T, Adelson R. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease. Circulation 1991;83:1294-1304.
9. 9. Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S. Adherence to national cholesterol education program treatment goals in postmenopausal women with heart disease. JAMA 1997;277:1281-1286.
10. 10. Blair TP, Bryant FJ, Bocuzzi S. Treatment of hypercholesterolemia by a clinical nurse using a stepped-care protocol in a nonvolunteer population. Arch Intern Med 1988;148:1046-1048.
11. 11. Pasternak RC, Grundy SM, Levy D, Thompson, PW. Spectrum of risk factors for coronary heart disease. J Am Coll Cardiol 1996;27:979-990.
12. 12. Schucker B, Wittes JT, Santanello NC, Weber SJ, McGoldrick D, Donato K, Levy A, Rifkind BM. Change in cholesterol awareness and action - results from national physician and public surveys. Arch Intern Med 1991;151:666-673.
13. 13. Solberg LI, Brekke ML, Kottke TE. How important are clinician and nurse attitudes to the delivery of clinical preventive services? J Fam Pract 1997;44: 451-461.
14. 14. Pearson TA, Myerson M. Treatment of hypercholesterolemia in women; equality, effectiveness an extrapolation of evidence. JAMA 1997;277:1320-1321.
15. 15. Forrester JS, Bairey Merz CN, Bush TL, Cohn JN, Hunninghake DB, Parthasarathy S, Superko R. Efficacy of risk factor management. J Am Coll Cardiol 1996;27:991-1006.
16. 16. Goldman L, Gordon DJ, Rifkind BM, Hulley SB, Detsky AS, Goodman DS, Kinosian B, Weinstein MC. Cost and health implications of cholesterol lowering. Circulation 1992;85:1960-1968.
17. 17. Goldman L, Garber AM Grover SA, Halatky MA. Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol 1996;27:1020-1030.
18. 18. Pearson TA, McBride PE, Miller NH, Smith SC. Organization of preventive cardiology service. J Am Coll Cardiol 1996;27:1039-1047.
19. 19. Shaffer J, Wexler LF. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Arch Intern Med 1995;155:2330-2335.